SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 28.33 |
Enterprise Value ($M) | 6.50 |
Book Value ($M) | 14.48 |
Book Value / Share | 0.35 |
Price / Book | 1.96 |
NCAV ($M) | 13.73 |
NCAV / Share | 0.33 |
Price / NCAV | 2.06 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -2.25 |
Return on Assets (ROA) | -0.97 |
Return on Equity (ROE) | -1.40 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 2.11 |
Current Ratio | 2.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 26.83 |
Assets | 27.58 |
Liabilities | 13.10 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Hirschman Orin | 4.80 | -28.93 | |
13G | Pathstone Family Office, Llc | 7.53 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
144,422 | 471,759 | 30.61 | |
164,711 | 588,457 | 27.99 | |
81,136 | 413,648 | 19.61 | |
(click for more detail) |
Similar Companies | |
---|---|
BTMD – biote Corp. | CADL – Candel Therapeutics, Inc. |
CARM – Carisma Therapeutics, Inc. | CHRS – Coherus BioSciences, Inc. |
CLSD – Clearside Biomedical, Inc. |
Financial data and stock pages provided by
Fintel.io